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Abstract
Total white blood cell (WBC) and neutrophil counts are lower among individuals of African descent due to the common
African-derived ‘‘null’’ variant of the Duffy Antigen Receptor for Chemokines (DARC) gene. Additional common genetic
polymorphisms were recently associated with total WBC and WBC sub-type levels in European and Japanese populations.
No additional loci that account for WBC variability have been identified in African Americans. In order to address this, we
performed a large genome-wide association study (GWAS) of total WBC and cell subtype counts in 16,388 African-American
participants from 7 population-based cohorts available in the Continental Origins and Genetic Epidemiology Network.
In addition to the DARC locus on chromosome 1q23, we identified two other regions (chromosomes 4q13 and 16q22)
PLoS Genetics | www.plosgenetics.org 1 June 2011 | Volume 7 | Issue 6 | e1002108associated with WBC in African Americans (P,2.5610
28). The lead SNP (rs9131) on chromosome 4q13 is located in the
CXCL2 gene, which encodes a chemotactic cytokine for polymorphonuclear leukocytes. Independent evidence of the novel
CXCL2 association with WBC was present in 3,551 Hispanic Americans, 14,767 Japanese, and 19,509 European Americans.
The index SNP (rs12149261) on chromosome 16q22 associated with WBC count is located in a large inter-chromosomal
segmental duplication encompassing part of the hydrocephalus inducing homolog (HYDIN) gene. We demonstrate that the
chromosome 16q22 association finding is most likely due to a genotyping artifact as a consequence of sequence similarity
between duplicated regions on chromosomes 16q22 and 1q21. Among the WBC loci recently identified in European or
Japanese populations, replication was observed in our African-American meta-analysis for rs445 of CDK6 on chromosome
7q21 and rs4065321 of PSMD3-CSF3 region on chromosome 17q21. In summary, the CXCL2, CDK6, and PSMD3-CSF3 regions
are associated with WBC count in African American and other populations. We also demonstrate that large inter-
chromosomal duplications can result in false positive associations in GWAS.
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Introduction
Proliferation and differentiation of hematopoietic stem cells into
mature white blood cells (WBC) in the bone marrow, followed by
release into the circulation of mature WBC, is a highly regulated
process [1]. WBC comprise several subtypes including neutrophils,
lymphocytes, monocytes, eosinophils, and basophils. These cells
play an essential role in innate and adaptive immunity against
invading microorganisms. They are also involved in the patho-
genesis of various acute and chronic diseases. The circulating
numbers of leukocytes can be influenced by stress, infection, or
inflammation. Total WBC and neutrophil counts also differ by
ethnicity, with levels 10–20% lower among African American than
European American populations [2,3]. This difference is due to a
common African-derived ‘‘null’’ variant (rs2814778) of the Duffy
Antigen Receptor for Chemokines (DARC) gene, which also
confers selective advantage against malaria [4–6]. By abolishing
expression of DARC on red blood cells, the Duffy null variant may
alter the concentration and distribution of chemokines in the blood
and tissue [7–10], thereby regulating neutrophil production and
migration.
Several clinically distinct forms of congenital neutropenia are
inherited as rare, monogenic disorders [11]. Genetic polymor-
phisms more common in the population, including those that
reside in the region of 17q21 harboring the CSF3 gene, were
recently associated with circulating total WBC and WBC subtype
counts in European and Japanese populations [12–15]. Yet these
common polymorphisms account for only a fraction of the
reported 50–60% heritability of WBC count [16–18]. In addition,
the contribution of these or other loci to variation in total WBC or
WBC subtypes have yet to be thoroughly evaluated through
current genome-wide association approaches in other populations,
such as African Americans. To identify additional polymorphisms
associated with WBC and its subtypes (neutrophils, lymphocytes,
monocytes, eosinophils, basophils), we therefore performed a
large, multi-cohort genome wide association study (GWAS) of
typed and imputed SNPs in African Americans, with follow-up in
additional ethnic samples of European and Japanese ancestry.
GWAS of WBC in African Americans
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We performed GWA analysis of total WBC in an African-
American discovery sample of 16,388 individuals from 7
population-based cohorts from the Continental Origins and
Genetic Epidemiology Network (COGENT). The characteristics
of each cohort are summarized in Table 1. Following stringent
genotyping and imputation quality control procedures, a total of
at least 2.4 million autosomal SNPs were available for analysis in
each cohort (Table S1). Summary-level study results were
combined by using inverse variance-weighted meta-analysis.
The genomic-control corrected QQ plot for the combined
African-African GWA analysis is shown in Figure 1. As
summarized in Table 2, Table S2, and the Manhattan plot in
Figure 2, three regions on chromosomes 1q23, 4q13, and 16q22
reached genome-wide significance at the threshold of
P,2.5610
28. These 3 loci are described in further detail below.
Additional GWA analyses were performed on a subset of up to
7,477 COGENT African American participants with data
available on WBC subtype counts (neutrophils, lymphocytes,
monocytes, eosinophils and basophils) (Figures S1 and S2, Tables
S3, S4, S5, S6, S7). Apart from the association of the
chromosome 1q23 DARC locus with neutrophils and monocytes
[6] (see below and Table 3), there were no new genome-wide
significant associations (all P.2.5610
28) for these phenotypes.
African American cohort-specific results for index SNPs newly
discovered or confirmed to be associated with WBC phenotypes
are summarized in Figure S3 (total WBC), Figure S4 (neutrophil
count), and Table S8.
Validation of DARC region on chromosome 1q23 as
WBC–associated locus in African Americans
The GWA association signal on chromosome 1 is comprised of a
broad peak encompassing 4,649 genotyped and imputed SNPs that
exceeded the threshold of genome-wide significance. This region
spans nearly 90 Mb on both arms of chromosome 1 (90,385,392–
177,814,914 bp) and is approximately centered around the
centromere. This results artifactually in two apparently distinct
peaks in the Manhattan plot (Figure 2) because of the lack of
genotyped or imputed SNPs around the centromere. Based on the
99% confidence interval of the distribution of test statistics, the
strongest region of association is concentrated between position
155,127,086 and 160,217,075 on the short arm of chromosome 1
(P=10
2154 to 10
2524). This region is centered around the DARC
gene locus on 1q23.2. DARC contains rs2814778 (the Duffy null
allele), previously identified as the likely causal chromosome 1q
WBC-associated polymorphism in an admixture mapping study
performed in the JHS and Health ABC cohorts, and confirmed in
ARIC [4,5]. As previously reported [4,5], the DARC rs2814778
association with WBC is most consistent with a dominant rather
than an additive model (P for dominance deviation ,10
240). For
example, in the largest cohort (WHI), the mean age- and global
ancestry-adjustedWBC count was 4,82361,004/ml inhomozygotes
for the African null allele, 6,30761,006/ml in heterozygotes, and
6,56361013/ml in homozygotes for the European wild-type allele.
Author Summary
Although recent genome-wide association studies have
identified common genetic variants associated with total
white blood cell (WBC) and WBC sub-type counts in
European and Japanese ancestry populations, whether
these or other loci account for differences in WBC count
among African Americans is unknown. By examining
.16,000 African Americans, we show that, in addition to
the previously identified Duffy Antigen Receptor for
Chemokines (DARC) locus on chromosome 1, another
variant, rs9131, and other nearby variants on human
chromosome 4 are associated with total WBC count in
African Americans. The variants span the CXCL2 gene,
which encodes an inflammatory mediator involved in WBC
production and migration. We show that the association is
not restricted to African Americans but is also present in
independent samples of European Americans, Hispanic
Americans, and Japanese. This finding is potentially
important because WBC mediate or have altered counts
in a variety of acute and chronic disorders.
Table 1. Characteristics of Continental Origins and Genetic Epidemiology Networks (COGENT) African-American discovery GWAS
participants (n=16,388).
Study
Atherosclerosis
Risk in
Communities
(ARIC)
Coronary Artery
Risk Development
in Young Adults
(CARDIA)
Johns Hopkins
Genetic Study of
Atherosclerosis
Risk (GeneSTAR)
Healthy Aging in
Neighborhoods of
Diversity across the
Life Span (HANDLS)
Health, Aging,
and Body
Composition
(Health ABC)
Jackson Heart
Study (JHS)
Women’s
Health
Initiative (WHI)
Sample size 2664 943 934 862 898 1992 8095
Study design Population-based,
unrelated
Population-based,
unrelated
Population-based,
family
Population-based,
unrelated
Population-based,
unrelated
Population-based,
unrelated
Population-
based, unrelated
Age, years (SD) 53.4 (5.8) 24.4 (3.8) 45.2 (12.6) 48.2 (9.0) 73.4 (2.8) 50.0 (12.1) 61.6 (7.0)
% Female 63.2 58.7 61.6 56.0 58.8 61.2 100
WBC (SD) 5.67 (1.85) 5.92 (2.00) 6.00 (1.90) 6.20 (1.97) 5.60 (2.00) 5.68 (1.91) 6.49 (1.50)
Neutrophils (SD) 2.89 (1.45) 3.11 (1.57) NA 3.485 (1.50) 5.20 (1.80)* 3.15 (1.51) NA
Lymphocytes (SD) 2.17 (0.75) 2.23 (0.84) 2.24 (0.71) 2.08 (0.69) 1.80 (0.70)* 1.96 (0.66) NA
Monocytes (SD) 0.344 (0.197) 0.314 (0.184) 0.308 (0.16) 0.386 (0.148) 0.400 (0.100)* 0.390 (0.145) NA
Eosinophils (SD) 0.165 (0.165) NA NA 0.150 (0.099) 0.200 (0.100)* 0.139 (0.126) NA
Basophils (SD) 0.037 (0.043) 0.046 (0.044) NA 0.026 (0.014) 0.055 (0.040)* 0.033 (0.022) NA
WBC and sub-type measures are reported in cells 610
9/liter [mean(SD)].
SD=standard deviation; NA=not available.
*In HABC, white blood cell sub-types were only available in a subset of participants (n=207).
doi:10.1371/journal.pgen.1002108.t001
GWAS of WBC in African Americans
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association might obscure any additional association signals
present on chromosome 1, we repeated the GWAS analysis
conditioning on the Duffy null rs2814778 polymorphism. All
chromosome 1 SNPs which were significantly associated with
WBC prior to rs2814778 adjustment became non-significant
conditional on rs2814778 genotype (data not shown). When the
association analysis was conducted separately for each white cell
subtype, the DARC rs2814778 polymorphism was most strongly
associated with the number of circulating neutrophils (P,10
2236)
(Table 3), but was also associated with the numbers of circulating
monocytes (P,10
226), and to a lesser extent, lymphocytes,
eosinophils, and basophils.
HYDIN region association on chromosome 16q22 is most
likely due to genotyping artifact
On chromosome 16q22, 13 SNPs spanning a ,250 kb region
(bp 69474507–69726247) that includes part of the large HYDIN
gene locus were significantly associated with WBC. The lead SNP
in the HYDIN region was rs12149261 (minor allele frequency or
MAF 25%), an intronic polymorphism. The HYDIN association
signal was confined to genotyped SNPs on the Affy6.0 array
(ARIC, CARDIA, JHS, WHI). SNPs in this region were absent
from the Illumina platform (Health ABC, GeneSTAR, HANDLS)
and also absent from HapMap 2, thereby limiting imputation in
the latter 3 cohorts.
Further examination of the sequence context in this region
revealed that the HYDIN gene encompasses a large, recently
duplicated segment of the genome, with a nearly identical 360-kb
paralogous segment inserted on chromosome 1q21 [19,20]. The
chromosome 1q21 paralogue of the chromosome 16q22 segmental
duplication is absent from build 36 of the NCBI human genome
assembly. Nonetheless, 1q21 falls within the region encompassing
the DARC association signal for WBC. Using genome-wide
Affymetrix 6.0 genotype data from the ARIC African-American
cohort, we determined the r-squared (pair-wise LD) between
Figure 1. Quantile–quantile plot of P-values in meta-analysis for total white blood count. Panel A includes all markers, panel B excludes
markers on chromosome 1. Horizontal axis indicates expected 2log10 P-values. Vertical axis indicates observed 2log10 P-values. The red line
represents y=x. The marked deviation from expectations in panel A is due to markers on chromosome 1 near the DARC locus. The individual study
ancestry-corrected inflation factors with (without) chromosome 1 markers were 1.06 (1.04) for ARIC, 1.02 (1.01) for CARDIA, 1.11 (1.08) for JHS, 1.03
(1.01) for Health ABC, 1.09 (1.05) for WHI, 1.04 (1.00) for GeneSTAR, and 1.01 (0.98) for HANDLS. The overall inflation factor prior to correction was 1.05
(0.98).
doi:10.1371/journal.pgen.1002108.g001
Table 2. Results of genome-wide significant SNPs for total white blood cell count.
Chromosome
Number SNPS
with P,2.5610
28
Top SNP in
region Position
Candidate
gene
Minor/Major
allele
Minor allele
frequency
Effect size
(Standard Error) P-value
1q23 .10,000 rs2814778 157441307 DARC T/C 0.21 +0.230 (0.005) 1.0610
2524
4q13 1 rs9131 75181913 CXCL2 T/C 0.23 20.023 (0.004) 1.6610
28
16q22 14 rs12149261 69555646 HYDIN A/C 0.25 +0.083 (0.005) 3.5610
275
For each locus, the lead SNP with the smallest P-values among the genotyped or imputed SNPs are indicated. Effect size represents the effect of a minor allele on natural
log-transformed white blood cell count. Positions of the SNPs were derived from dbSNP build 136.
doi:10.1371/journal.pgen.1002108.t002
GWAS of WBC in African Americans
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was reduced local LD within the chromosome 16 duplicated
region, relative to the surrounding chromosome 16 SNP (Figure
S5). Three SNPs had r-squared values of .0.20 with rs12149261:
one located 20 kb away on chromosome 16 in the HYDIN gene
(rs1774524; r2=0.27), and two located on chromosome 1 at
,120 Mb near the HYDIN paralogue (rs12087334 and
rs4659245; r2=0.25 and 0.22, respectively). Moreover, com-
bined analysis of the 4 cohorts typed on the Affymetrix GWA
platform showed that the chromosome 16q22 association signal
at rs12149261 (P=2.12 610
218) was completely abolished after
conditioning on chromosome 1 DARC rs2814778 (P=0.36).
While defects in the HYDIN gene result in hydrocephalus [19,20],
this genomic region has not previously been associated with
WBC. Together, these results demonstrate that the chromosome
16 HYDIN association finding is most likely a probe cross-
hybridization artifact due to inter-chromosomal sequence simi-
larity with the duplicated segment on chromosome 1q21 near the
DARC region and that the polymorphisms associated with WBC
in the studies using the Affymetrix arrays actually map to the
chromosome 1 region.
Discovery of a novel CXCL2 association finding on
chromosome 4q13 and replication in other ethnic
populations
A novel SNP association on chromosome 4q13 was identified
in our African-American WBC discovery GWAS. The lead SNP
rs9131 is located in the 39 UTR of the CXCL2 gene, which
encodes a macrophage-derived chemotactic cytokine for
polymorphonuclear leukocytes. In African Americans, the
minor T allele (MAF=23%) was associated with lower WBC.
Several additional SNPs in the chromosome 4 chemokine gene
cluster had P-values ranging from 10
25 to 10
27, including
rs2367291 located upstream of CXCL1 (Figure 3A) Further
adjustment for rs9131, however, abolished these associations
(data not shown). Based on HapMap phase 2 and 1000 genomes
data, rs9131 is in perfect LD with 7 other inter-genic SNPs in
Figure 2. Manhattan plot of meta-analysis P-values in GWAS for total WBC count. Horizontal axis indicates chromosomal position. Vertical
axis indicates 2log10 P-values from inverse variance-weighted fixed effects meta-analysis. The red horizontal line indicates the genome-wide
significance threshold of P=2.5610
28. Association signals are present at 1q23, 4q13, and 16q22. The P-values for the broad chromosome 1 signal are
truncated at 10
220. This region spans nearly 90 Mb on both arms of chromosome 1 and results artifactually in two apparently distinct peaks because
of the lack of genotyped or imputed SNPs around the centromere.
doi:10.1371/journal.pgen.1002108.g002
Table 3. Meta-analysis results of genome-wide significant SNPs for white blood cell count subtypes.
Cell type Chromosome 1q23 DARC rs2814778 T allele Chromosome 4q13 CXCL2 rs9131 T allele
N Effect size (Standard Error) P-value N Effect size (Standard Error) P-value
Neutrophils 5609 +0.305 (0.009) 1.0610
2237 7353 20.038 (0.008) 1.5610
26
Lymphocytes 5642 +0.020 (0.007) 3.8610
23 7390 +0.010 (0.005) 0.06
Monocytes 5593 +0.048 (0.004) 6.0610
227 7330 20.004 (0.004) 0.23
Eosinophils 5411 +0.012 (0.003) 8.6610
25 6402 20.0005 (0.003) 0.85
Basophils 5104 +0.002 (0.0008) 3.5610
23 6052 20.0007 (0.0007) 0.27
Effect size represents the effect of a minor allele on natural log-transformed white blood cell count.
doi:10.1371/journal.pgen.1002108.t003
GWAS of WBC in African Americans
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participants with data available for number of circulating white
cell subtypes indicated the rs9131 association was confined to
neutrophils (Table 3).
To assess the role of the newly identified CXCL2 association in
other ethnic populations, we performed in silico replication using 3
samples: 3,551 Hispanic-American women from WHI-SHARe,
19,509 European-American participants from the CHARGE
consortium, and 14,767 Japanese subjects from RIKEN. In
Europeans, Hispanics, and Japanese, the T allele of rs9131
(frequency=65%, 62%, and 46%, respectively) was associated
with lower WBC (P=0.004, 0.002, and 9.4610
27, respectively), as
was seen in African Americans (P=2 610
28). The direction and
magnitude of association was consistent across racial/ethnic
groups: 0.00960.003, 0.01860.006, and 0.01360.003 natural
log units lower in Europeans, Hispanics, and Japanese, respec-
tively, compared to 0.02360.004 natural log units lower WBC
count in the African-American discovery sample. Pooling the
results across populations using a random effects meta-analysis
gave a combined effect estimate (beta for lnWBC) of 20.015
(95%CI=20.009 to 20.021) for rs9131. The P for Cochrane’s Q
test for heterogeneity was 0.04, with an I
2 of 64%. In contrast,
there was no evidence that the chromosome 1 DARC region was
associated with WBC count in either European or Japanese
populations (data not shown).
Regional plots comparing the SNP association and linkage
disequilibrium patterns across CXCL2 on chromosome 4 in
African Americans, Europeans, and Japanese 4 are shown in
Figure 3. In Europeans and Japanese, several additional SNPs in
the CXCL2 region of chromosome 4 had stronger association
WBC signals than rs9131. Specifically, rs16850408, which is
located in an inter-genic region between CXCL2 and the pro-
platelet basic protein-like 2 gene (PPBPL2), was most strongly
associated with WBC (P=8.04610
26) in Europeans. The r-
squared between rs16850408 and rs9131 is 0.76 in European and
0.3 in African HapMap samples. In Japanese, rs7686861 located
in the intergenic region between CXCL2 and MTHFD2L
(methylenetetrahydrofolate dehydrogenase 2-like) was the lead
SNP (P=3.4610
28). The r-squared between rs7686861 and
rs9131 is 0.21 in Asian and 0.23 in African HapMap samples. To
further narrow the locus of WBC count association, we performed
a sample size-weighted meta-analysis of the CXCL2 region across
all 3 ethnic groups. The cross-population association signal
mapped to a 75 kb region (positions 75,155,842–75,231,250),
which contains CXCL2 and no other genes in the chromosome
4q13 region. The top SNPs included rs1371799 (P=1.7610
217)
as well as several others located within the CXCL2 promoter and 59
flanking region (Figure 4).
Assessment of other previously discovered WBC–
associated loci in African-Americans
Several GWAS loci have been published from European or
Japanese cohorts, including those associated with WBC (GSDMA-
ORMDL3-PSMD3-CSF3, HSB1L-MYB, CDSN-PSORS1C1, CDK6,
and RAP1B), neutrophil count (PSMD3-CSF3, PLCB4), and
eosinophil count (IL1RL1, IKZF2, GATA2, IL5, SH2B3)[ 1 2 –
15]. Table 4 shows the association results of these same loci in our
African-American sample, for the originally reported index SNP.
Extending the association analyses to SNPs in LD with the index
SNP (r
2$0.5 in HapMap CEU or CHB+JPT) did not reveal
any additional associations (data not shown). For the chromo-
some 17 PSMD3–CSF3 region, the T allele of rs4065321 reported
to be associated with lower WBC in Japanese was similarly
associated with lower total WBC in African-Americans
(P=1 610
24). Most of the African-American WBC-associated
SNPs in this region were intronic to PSMD3,w h i l eo n eS N P
(rs7224260) is located in the 39 flanking region of CSF3.T h eT
allele of CDK6 rs445 was associated with lower total WBC
(Table 4), and also with lower neutrophil count in 7,392 African
Americans (beta 20.024960.0049; p=1.7610
27). The remain-
ing European and Japanese WBC-association genomic regions
listed in Table 4 showed little evidence of replication in African
Americans.
Effect of locus-specific ancestry on newly and previously
reported WBC–associated SNPs
In recently admixed populations, it is possible that confounding
of a SNP association may occur as a result of local as well as global
differences in genetic ancestry between study participants [21].
Therefore, we repeated the association analyses for any newly
reported African American or previously reported European and
Japanese genome-wide significant WBC-associated loci, addition-
ally adjusting for estimated local ancestry in our COGENT
African American study participants. We performed these locus-
specific ancestry conditional analyses in a subset of 13,694
participants from each of the 4 cohorts genotyped on Affymetrix
6.0 (WHI, ARIC, CARDIA, and JHS). After meta-analyzing the
African American cohort-specific results, there was essentially no
difference between the local ancestry adjusted versus global
ancestry-adjusted associations at any of the WBC-associated loci
(Table S9). However, when we performed an additional
association analysis for each lead SNP stratifying on the estimated
local number of European versus African chromosomes, the CDK6
rs445 and PSMD3-CSF3 rs4065321 WBC associations were
stronger on a local European ancestral background than on an
African background (Table S9). Notably, the CDK6 and PSMD3-
CSF3 loci are also the only two previously reported WBC
associations that we were able to replicate in our African
American sample. For European and Japanese WBC-associated
loci that didn’t replicate in our African American sample, there
was no evidence of any differential association according to local
ancestral background or proportion of European ancestry in the
AA sample (data not shown).
Heritability of WBC phenotypes in African Americans and
proportion of variance explained
Polygenic heritability was estimated for unadjusted and age-
and sex-adjusted total WBC, neutrophil, lymphocyte, and
monocyte count using 236 African-American pedigrees from the
GeneSTAR study (Table S10). All WBC phenotypes showed
significant heritability (P,0.001). The heritability estimates ranged
from 48–49% for total WBC and neutrophil count to ,29% for
monocyte count. The proportion of total variance explained by
DARC rs2814778+CXCL2 rs9131+CDK6 rs445+PSMD3-CSF3
Figure 3. Population-specific 2log P values for total WBC association at the chromosome 4q13 CXCL2 locus. Shown is a 500 kb window
of chromosome 4q13 centered at rs9131 (purple square). Plots were generated for African Americans (top panel), European Americans (middle panel),
Japanese (bottom panel), using LocusZoom. The color of each SNP indicates the level of pairwise linkage disequilibrium (r-squared) relative to the
index SNP rs9131. R-squared values were calculated from HapMap (release 22) YRI (top panel), CEU (middle panel), or CHB+JPT (bottom panel)
populations. SNPs with missing LD information are shown in grey.
doi:10.1371/journal.pgen.1002108.g003
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PLoS Genetics | www.plosgenetics.org 7 June 2011 | Volume 7 | Issue 6 | e1002108rs4065321 in the COGENT African American cohorts ranged
from 16% to 24% for WBC, 20% to 25% for neutrophils, and 2%
to 7% for monocytes.
Since multiple, independent variants at the same locus may
account for some of the ‘‘missing heritability’’ of complex traits [22],
we repeated the association tests for all genotyped SNPs within
500 kb of the DARC, CXCL2, CDK6,a n dPSMD3-CSF3 gene
regions for WBC association, conditioning on the lead SNP in each
region.Noneofthe 4locicontainedadditionalSNPsassociated with
WBC at P,2.5610
25 (a Bonferroni-corrected significance thresh-
old calculated from the 2,000 SNPs tested in these 4 regions).
Discussion
Recently the African null allele of rs2814778 at the Duffy
Antigen Receptor for Chemokines locus on chromosome 1 was
found to be associated with lower total leukocyte and neutrophil
counts in African Americans [4–6]. By screening 16,388 African-
Figure 4. Trans-population meta-analysis results for total WBC count at the chromosome 4q13 CXCL2 locus. The strongest association
signal is localized to an LD bin of several SNPs within the CXCL2 promoter and 59 flanking region, including rs1371799 (purple triangle). Meta-analysis
was performed using Fisher’s method to combine P-values across African, European, and Japanese populations. The 99% confidence interval for the
cross-population association signal mapped to a 75 kb region shaded in light blue (lower panel). Plot was generated using LocusZoom. Linkage
disequilibrium is shown for the African population.
doi:10.1371/journal.pgen.1002108.g004
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association. We also identified a second chemokine-related gene
region associated with lower WBC, with the lead SNP rs9131
located in the CXCL2 gene. Independent evidence of the novel
CXCL2 association was present in other ethnic populations,
including ,3,500 Hispanic Americans, ,15,000 Japanese, and
,20,000 European Americans. Two additional WBC loci recently
identified through GWAS of European or Japanese populations
(CDK6 gene region on chromosome 7 and PSMD3-CSF3 region on
chromosome 17 [12–14] were associated with WBC traits in
African Americans. We also demonstrate that large inter-
chromosomal duplications can result in false positive associations
in GWAS as was shown for HYDIN.
Our estimate of heritability for total WBC and neutrophil count
in African Americans was close to 50%, which is similar to that
reported in European populations [16–18]. While our GWAS has
identified a few, select loci to be associated with WBC count in
African Americans, the proportion of variation explained for WBC
and neutrophil count was still less than 25%, and considerably
lower for the remaining WBC subtypes. Therefore it seems likely
that in addition to the DARC and CXCL2 loci, other yet-to-be
identified loci exist. Alternatively, genetic factors may account for
a lower percentage of the variance in WBC count than suggested
by heritability estimates and perhaps environmental factors should
be more broadly considered. Other factors may have limited our
ability to identify genetic mechanisms underlying these traits,
including phenotype measurement error and reduced sample size
and power for the WBC subtype GWA analyses. Multiple rare
genetic variants or gene-gene and gene-environment interaction
may also account for some of the inter-individual variation of these
hematologic traits.
Myelopoiesis is regulated by a number of cytokines, chemo-
kines, growth factors, and their receptors. The cytokine granulo-
cyte colony-stimulating factor (G-CSF), encoded by the CSF3 gene
on chromosome 17, is critically involved in granulopoiesis by
stimulating proliferation, differentiation, and survival of neutrophil
precursors [23] and by regulating the rate of release of neutrophils
from the bone marrow under non-inflammatory conditions [24].
During infection or inflammation, neutrophil, monocyte and
eosinophil mobilization from the bone marrow can occur through
the systemic and/or local action of several chemokines, which
stimulate chemotaxis across the bone marrow sinusoidal endothe-
lium. G-CSF stimulates neutrophil mobilization and release by
down-regulating signaling of stromal-derived factor 1 (CXCL12)
through its receptor CXCR4, which serves as a bone marrow
retention signal for mature neutrophils [23,25]. In contrast, the
chemokines CXCL1 and CXCL2, by binding to CXCR2,
promote rapid release of neutrophils from the bone marrow,
thereby elevating blood neutrophil counts during infection or
during G-CSF-induced neutrophil mobilization [25–27].
DARC is selectively expressed on red blood cells and venular
endothelial cells and binds several pro-inflammatory chemokines
of both the CXC and CC subfamilies. Endothelial DARC
facilitates leukocyte recruitment and trans-endothelial migration,
thereby contributing to inflammatory disease pathogenesis and
severity in animal models [28–30]. Erythrocyte DARC has been
proposed to act as a chemokine scavenger, sink or reservoir,
maintaining basal plasma chemokine concentrations, though the
biological relevance of this sink function remains unclear [6–9].
The African Duffy null variant disrupts a DARC promoter binding
site for the transcription factor GATA-1, and results in complete
absence of DARC from erythrocytes without affecting endothelial
DARC expression [31]. Duffy-negative individuals are protected
from P. vivax malaria [32,33] and have been reported to have a
survival advantage in leukopenic HIV-infected persons of African
descent [34]. Interestingly, during systemic inflammation neutro-
phils from DARC-deficient mice exhibit impaired chemotaxis
toward CXCL2 that appears to result from altered plasma
chemokine levels and down-regulation of neutrophil CXCR2
expression [29]. It is conceivable that a homeostatic role of DARC
in CXCL1/CXCL2- CXCR2 chemokine ligand-receptor inter-
actions during inflammation may also extend to the setting of
neutrophil release from the bone marrow under both basal and
inflammatory conditions.
Nucleotide diversity can vary substantially across populations due
to different evolutionary histories and migration patterns. Generally,
nucleotide diversity is greatest and linkage disequilibrium lowest
among African populations. By leveraging the extent of variation
in LD patterns between populations, localization of causal
variants can be improved by analyzing multiple ethnic groups
[35–38]. By combining WBC count association results from the
CXCL2 region across African Americans, European Americans,
and Japanese, we were able to narrow the association signal to
the CXCL2 promoter and 59 flanking region.
The multi-gene region on chromosome 17q21.1 has now been
associated with WBC or neutrophil count in Europeans [12],
Japanese [13,14], and African Americans. The index SNPs origi-
nally reported (rs17609240, rs4065321, rs4794822, rs2305481) for
these traits are in strong to moderate LD in Europeans and
Japanese (r
2=0.5 to 1.0), spanning an LD block that includes
several genes (GSDMA, ORMDL3, PSMD3, CSF3, MED24,
SNORD124, and THRA). The lower extent of LD in African-
Americans suggests finer localization of the rs4065321 WBC-
associated signal to the region containing PSMD3 and CSF3.
Other variants in this region have been associated with childhood-
onset asthma [39]. CSF3, which encodes G-CSF, constitutes the
most likely biologic candidate in this region responsible for
phenotypic variation in WBC. However, the functional SNPs
responsible for variation in WBC phenotypes remain to be
identified. Expression (eQTL) analysis demonstrated that the SNP
associated with neutrophil count by Okada et al was associated
with PSMD3 expression, rather than CSF3 expression [14].
PSMD3 encodes one of the non-ATPase subunits of the 19S
regulator of 26S proteasome, which is involved in regulation of the
cell cycle through the ubiquitin–proteasome pathway.
The current analysis also replicated the association between
WBC count and a region on chromosome 7 containing the gene
for CDK6, or cyclin-dependent kinase 6, another regulator of cell
cycle progression known to be expressed in proliferating
hematopoietic progenitor cells [40]. Through its interaction with
the transcription factor Runx1, CDK6 inhibits terminal granulo-
cytic differentiation [41]. For the chromosome 7 WBC locus,
rs445 is located within the first intron of CDK6, and represents the
lead SNP in both Japanese [13] and our African American sample.
There is no other variant in strong LD (r-squared.0.8) with rs445
in any HapMap or 1000 Genomes population. Therefore it is
possible that CDK6 rs445 may represent the actual causal variant.
Other polymorphisms within the CDK6 gene have been associated
with susceptibility to rheumatoid arthritis [42] and height [43].
Benign neutropenia is defined as an absolute neutrophil count
(ANC) of less than 1.5610
9 cells/L on repeated occasions [2,44].
It occurs in up to 40% of individuals of African descent [2] and is
present in ,5% of adult African Americans compared to ,1% of
European Americans [3]. The benign neutropenia of African
Americans is characterized by normal myeloid maturation, but
slightly reduced numbers of bone marrow myeloid progenitors
[45,46] and reduced numbers of mature neutrophils that can be
released from bone marrow stores [47]. Despite having slightly
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+ hematopoietic progenitor
cells, African Americans paradoxically appear to have enhanced
peripheral blood stem-cell mobilization in response to adminis-
tration of G-CSF compared to whites [44,48]. The genetic
determinants of these features of G-CSF-induced stem cell
mobilization remain to be determined.
In summary, polymorphisms within DARC on chromosome 1
and CXCL2 on chromosome 4, and near CDK6 on chromosome 7
and CSF3 on chromosome 17, are associated with WBC in African
Americans. These findings contribute to our understanding of
genetic factors underlying variation in WBC within and between
populations and highlight the importance of common genetic
variants in genomic regions encoding chemokine ligands and
receptors to regulation of myelopoiesis and circulating leukocyte
counts in human populations. Further localization and character-
ization of the functional variants responsible for these WBC and
neutrophil associations could help to inform clinical approaches to
cancer-associated neutropenia or hematopoietic stem cell mobili-
zation.
Methods
Subjects
The subjects participating in the GWAS consisted of a total of
16,388 self-identified African-American individuals from 7 popu-
lation-based cohorts (ARIC, CARDIA, JHS, WHI, HANDLS,
Health ABC, and GeneSTAR) that belong to the Continental
Origins and Genetic Epidemiology Network (COGENT). Detailed
descriptions of each participating COGENT cohort, their quality
control practices and study-level analyses are provided in the Text
S1. Clinical information of the subjects was collected by self-report
and clinical examination. All participants provided written
informed consent as approved by local Human Subjects
Committees. We excluded study participants on the basis of
pregnancy, cancer, or AIDS diagnosis at the time of blood count
measurement.
WBC phenotype data
Certified staff obtained fasting blood samples at the baseline
clinic visit. Samples for complete blood count (CBC) analysis were
obtained by venipuncture and collected into tubes containing
ethylenediaminetetraacetic acid (EDTA). Total circulating WBC
count and cell subtype counts were performed at local clinical
laboratories using automated hematology cell counters and
standardized quality assurance procedures [4,6,49–51]. Total
WBC count was reported in millions of cells per ml, and was
recorded in all 16,388 study participants. Information on WBC
subtype was available only in a subset of 7,477 (45.6%)
participants from ARIC, CARDIA, JHS, HANDLS, GeneSTAR,
and Health ABC. WBC differentials were performed by clinically
certified hematology laboratories. The absolute numbers of each
type of WBC were calculated by multiplying the proportion of the
WBC count comprised by each cell type by the total WBC
measure. To evaluate normality of the phenotypes for subsequent
regression analyses, we performed Box-Cox likelihood ratio tests
on raw WBC phenotypes. On this basis, all WBC traits were
natural log transformed to normalize the distributions of the
phenotypic data.
Genotype data and quality control
Genome-wide genotyping was performed within each CO-
GENT cohort using methods described under Text S1. DNA
samples with a genome-wide genotyping success rate ,90%,
duplicate discordance or sex mismatch, genetic ancestry outliers
(as determined by cluster analysis performed using principal
component analysis or multi-dimensional scaling), SNPs with
genotyping success rate ,95%, monomorphic SNPs, SNPs with
minor allele frequency (MAF) ,1%, and SNPs that map to several
genomic locations were removed from the analyses. Significantly
associated SNPs were examined for strong deviations from Hardy–
Weinberg equilibrium and/or raw genotype data examined for
abnormal clustering. Participants and SNPs passing basic quality
control were imputed to .2.2 million SNPs based on HapMap2
haplotype data using a 1:1 mixture of Europeans (CEU) and
Africans (YRI) as the reference panel. Details of the genotype
imputation procedure are described further under Text S1. Prior
to discovery meta-analyses, SNPs were excluded if imputation
quality metrics (equivalent to the squared correlation between
proximal imputed and genotyped SNPs) were less than 0.50.
Data analysis
For all cohorts, genome-wide association (GWA) analysis for
quantitative WBC traits was performed using linear regression
adjusted for covariates, implemented in either PLINK v1.07 [52]
or MACH2QTL v1.08. Allelic dosage at each SNP was used as
the independent variable, adjusted for primary covariates of age,
age-squared, sex, and clinic site (if applicable). To adjust for
population stratification and global admixture, the principal
components were also incorporated as covariates in the regression
models (see Text S1). For GeneSTAR, family structure was
accounted for in the association tests using linear mixed effects
(LME) models implemented in R [53]. Although the JHS has a
small number of related individuals, extensive analyses showed
that results were concordant using linear regression or LME, after
genomic control. Therefore, results are presented for JHS using
linear regression. For imputed genotypes, we used dosage
information (i.e. a value between 0.0–2.0 calculated using the
probability of each of the three possible genotypes) in the
regression model implemented in PLINK and MACH2QTL (for
cohorts with unrelated individuals) or the Maximum Likelihood
Estimation (MLE) routines (for GeneSTAR).
For each WBC phenotype, meta-analyses were conducted using
inverse-variance weighted fixed-effects models to combine beta
coefficients and standard errors from study level regression results
for each SNP to derive a combined p-value and effect estimates.
Study level results were corrected for genomic inflation factors (l)
by incorporating study specific l estimates into the scaling of the
standard errors (SE) of the regression coefficients by multiplying
the SE by the squate-root of the genomic inflation factor. The
inflation factors for all completed analyses are presented in Table
S1. Meta-analyses were implemented in the software METAL [54]
and were performed independently by another analyst to confirm
results. Between-study heterogeneity of results was assessed by
using Cochran’s Q statistic and the I
2 inconsistency metric. For
each genome-wide significant or replicated locus, cohort specific-
results and overall WBC effect estimates and confidence intervals
are summarized using forest plots (Figure S3 and S4). The mean
and standard deviation WBC count for each genotype class is
provided in Table S8.
To maintain an overall type 1 error rate of 5%, a threshold of
a=2.5610
28 was used to declare genome-wide statistical
significance. This threshold has been suggested for African
ancestry populations based on estimates of ,2 million indepen-
dent common variant tests in African genomes [55].
Given the nonlinear nature of the original phenotype, we
performed a sensitivity analysis of whether our results are robust to
the assumption of an additive genetic model. We repeated the
GWA analysis for the WHI, ARIC, CARDIA, JHS cohorts, the
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degree of freedom genotypic model as well as a dominance
deviation test, and meta-analyzed the results using METAL.
To assess in the COGENT African-Americans WBC trait-
associated loci previously reported in Europeans or Japanese, we
evaluated the African-American meta-analysis results for each
index SNP in the regions reported, including consistency of
direction of effect, and assessed statistical significance by a simple
Bonferroni adjustment based on the total number of SNPs assessed
using a 2-sided hypothesis test. In addition, we performed a more
exploratory assessment of all SNPs within a 500 kb window that
were correlated in African Americans with the European or
Japanese index SNP in HapMap CEU or CHB+JPT (r
2$0.5). We
adjusted these exploratory regional analyses for multiple testing
based on the effective number of SNPs, taking into account
pairwise linkage disequilibrium patterns.
To further assess the potential existence of multiple, indepen-
dent variants influencing a trait at the same locus (allelic
heterogeneity), regression analyses were repeated, conditional on
the most strongly associated (index) SNP in that region. Each study
repeated the primary GWA analysis, additionally adjusting for the
lead SNP in each region under the appropriate regression models.
The cohort-specific results were then meta-analyzed in the same
way as for the primary GWA study using METAL.
Replication and fine-mapping of new WBC association
signals
Replication of novel association findings was performed using
GWA data in 3 other ethnic populations: 3,551 Hispanic
American women from WHI, 14,767 Japanese from RIKEN,
and 19,509 European Americans from CHARGE. Further details
of each study population are provided under Text S1. Both
genotyped and imputed SNP data were available in the European
and Japanese samples, while only genotyped SNP data were
available in the Hispanic Americans. To further localize the causal
variant responsible for the CXCL2-WBC association, we extended
the association analysis to include all genotyped and imputed
SNPs within a 500 kb region centered at rs9131, the SNP most
strongly associated with WBC count in African Americans. We
then performed a trans-population meta-analysis of each SNP in
this region by combining test statistics from the African American
(COGENT), European (CHARGE), and Japanese (RIKEN)
association analyses using Fisher’s method [56], which may have
some advantages over the standard meta-analytic approach in this
setting [37]. Nonetheless, we also performed a standard inverse
variance-weighted meta-analysis using either fixed or random
effects [57], and obtained results similar to Fisher’s method.
Local ancestry analyses
For between-study GWA platform consistency, we estimated
locus-specific ancestry using Affymetrix 6.0 genotyped SNP data
from the 4 largest African-American cohorts (WHI, ARIC, JHS,
CARDIA), which constitute ,85% of our total COGENT African
American sample. For each African American, locus-specific
ancestry (probabilities of whether an individual has 0, 1, or 2
alleles of African ancestry at each locus) was estimated using a
Hidden Markov Model and local haplotype structure to detect
transitions in ancestry along the genome [58,59]. Phased
haplotype data from the HapMap CEU and YRI individuals
were used as reference panels. To assess the impact of local
ancestry on any genome-wide SNP associations, each of the 4
cohorts repeated each SNP genotype-WBC phenotype linear
regression model, adjusting for local ancestry proportion as a
covariate. In addition, we stratified the SNP genotype-WBC
phenotype association test on the number of estimated local
European chromosomes ($1 versus ,1) to compare whether
variants in genome-wide significant regions have the same versus
different effect on African and European ancestral population
backgrounds. The cohort-specific results of these analyses were
combined using METAL.
Heritability and proportion of variance explained
In the GeneSTAR family study, variance components models in
the ASSOC subroutine of S.A.G.E. [60] were used to derive
maximum likelihood estimates of polygenic (narrow-sense) heritability
(s
2
g) using natural-log transformed unadjusted or covariate-adjusted
phenotype data. The statistical significance of the heritability
estimate was obtained using a likelihood ratio test. In each of the
7 COGENT African American cohorts, the fraction of variance
explained was estimated using the formula: 2pq6b
2,w h e r ep is
the frequency of the effect allele of the SNP, q=12p,a n db is the
additive effect in each population estimated by standardizing
WBC to have standard deviation 1.
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